Patients with mutations in the DOCK family (DOCK1 and DOCK2), which are crucial regulators of tumor and leukocyte migration, had worse DFS (Cox regression, DOCK1 hazard ratio (HR): 2.39 (1.29–4.45), p = 0.006; DOCK2 HR: 1.98 (1.04–3.77), p = 0.041, Figure S4). This evidence concerns the gene DOCK2 and neoplasm.